Palatin Technologies, Inc. (LON:0KF3)
London · Delayed Price · Currency is GBP · Price in USD 10.25
-0.61 (-5.62%)
Jul 7, 2026, 2:42 PM GMT
Palatin Technologies Revenue
Palatin Technologies had revenue of $3.92M USD in the quarter ending March 31, 2026.
Revenue (ttm)
$9.76M
Revenue Growth
+3,581.22%
P/S Ratio
1.40
Revenue / Employee
$336.46K
Employees
29
Market Cap
13.63M GBP
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 4.49M | -363.59K | -7.49% |
| Jun 30, 2023 | 4.85M | 3.39M | 230.53% |
| Jun 30, 2022 | 1.47M | 1.66M | - |
| Jun 30, 2021 | -188.60K | -306.59K | - |
| Jun 30, 2020 | 117.99K | -60.18M | -99.80% |
| Jun 30, 2019 | 60.30M | -6.83M | -10.18% |
| Jun 30, 2018 | 67.13M | 22.41M | 50.11% |
| Jun 30, 2017 | 44.72M | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | 12.95M | - | - |
| Jun 30, 2014 | - | - | - |
| Jun 30, 2013 | 10.36K | -63.38K | -85.95% |
| Jun 30, 2012 | 73.74K | -1.40M | -95.00% |
| Jun 30, 2011 | 1.48M | -12.71M | -89.60% |
| Jun 30, 2010 | 14.18M | 2.83M | 24.92% |
| Jun 30, 2009 | 11.35M | - | - |
| Jun 30, 2008 | - | - | - |
| Jun 30, 2007 | - | - | - |
| Jun 30, 2006 | 19.75M | 1.79M | 9.98% |
| Jun 30, 2005 | 17.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IXICO | 7.28M |
| SkinBioTherapeutics | 5.23M |
| Arecor Therapeutics | 1.71M |
| Fusion Antibodies | 1.60M |
| Aptamer Group | 1.38M |
| OptiBiotix Health | 1.17M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 231.00K |
Palatin Technologies News
- 12 days ago - Palatin Technologies Proxy statement: Proxy filing - Filings
- 20 days ago - Palatin Technologies Is Pursuing the Next Generation of MC4R. ... - GuruFocus
- 5 weeks ago - Palatin Technologies Slides: Corporate presentation - Filings
- 7 weeks ago - Palatin announces approval of its common stock by Nasdaq - TheFly
- 7 weeks ago - Palatin to Begin Trading on Nasdaq Stock Exchange - PRNewsWire
- 7 weeks ago - Palatin price target lowered to $47.50 from $50 at Alliance Global - TheFly
- 7 weeks ago - Palatin Technologies Earnings Call Transcript: Q3 2026 - Transcripts
- 7 weeks ago - Palatin Technologies Earnings release: Q3 2026 - Filings